Literature DB >> 23718885

Relationship between preoperative serum TSH levels and expression of VEGF in papillary thyroid carcinoma.

Jin Li1, Lisong Teng, Honggang Jiang.   

Abstract

AIM: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Increased expression of VEGF has been observed in papillary thyroid carcinoma (PTC). Thyroid stimulating hormone (TSH) is the major thyroid hormone, but its relationship with VEGF has seldom been studied. Therefore, we explored whether the immunohistochemical expression of VEGF was related to the serum TSH level.
METHODS: VEGF expression was analyzed in 43 archived PTC specimens using immunohistochemistry, with adjacent normal thyroid tissues used as controls. Serum TSH was measured by immunoradiometric assay before surgery and correlated to VEGF expression.
RESULTS: Positive VEGF expression was found in 90% of 43 PTC tissue specimens, but not in normal tissue. The serum TSH levels revealed a positive correlation with VEGF expression, R = 0.592 (P < 0.01).
CONCLUSIONS: TSH is a major thyroid hormone. Whether TSH promotes the progression of PTC is not known but the serum TSH levels reveal a positive correlation with VEGF expression.
© 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  immunohistochemistry; papillary thyroid carcinoma; thyroid stimulating hormone; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23718885     DOI: 10.1111/ajco.12075

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  5 in total

1.  Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.

Authors:  De-Feng Chang; Zhong-Qing Xu; Bin Sun
Journal:  Tumour Biol       Date:  2014-02-21

2.  Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.

Authors:  Xiao-Qing Huang; Wen-Shan He; Hui-Qiong Zhang; Rui Yang; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

3.  Major Vault Protein (MVP) Associated With BRAF V600E Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways.

Authors:  Xubin Dong; Percy David Papa Akuetteh; Jingjing Song; Chao Ni; Cong Jin; Huihui Li; Wenjie Jiang; Yuhao Si; Xiaohua Zhang; Qiyu Zhang; Guanli Huang
Journal:  Front Cell Dev Biol       Date:  2022-03-31

4.  Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions.

Authors:  Deepak Bariya; Shashi Prakash Mishra; B R Akshay; Sweety Kumari; Rahul Khanna; Ram Niwas Meena
Journal:  J Family Med Prim Care       Date:  2022-06-30

5.  Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study.

Authors:  Juan Zhu; Kexin Sun; Jian Wang; Yutong He; Daojuan Li; Shuzheng Liu; Yunchao Huang; Min Zhang; Bingbing Song; Xianzhen Liao; He Liang; Qian Zhang; Mumu Shi; Lanwei Guo; Yongchun Zhou; Yanping Lin; Yanni Lu; Jiyu Tuo; Yafen Xia; Huixin Sun; Haifan Xiao; Yong Ji; Ci Yan; Jinwan Qiao; Hongmei Zeng; Rongshou Zheng; Siwei Zhang; Shaoyan Liu; Sheng Chang; Wenqiang Wei
Journal:  Front Public Health       Date:  2022-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.